Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-256022

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Joseph Douglas Lyon
Officer — See Remarks
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 7:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001088856

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jun 1, 2026A537$70.44A6,767D
Common StockF4,F3Jun 1, 2026A537$0.00A7,304D
Common StockF6,F7Jun 2, 2026F269$70.44D7,035D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Chief Accounting & Technology Officer